Innoviva (INVA) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 74.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.91% |
| Dec 31, 2025 | -10.20% |
| Sep 30, 2025 | -30.30% |
| Jun 30, 2025 | 307.82% |
| Mar 31, 2025 | -70.47% |
| Dec 31, 2024 | -20.34% |
| Sep 30, 2024 | -74.42% |
| Jun 30, 2024 | -33.70% |
| Mar 31, 2024 | -27.06% |
| Dec 31, 2023 | -28.50% |
| Sep 30, 2023 | 42.73% |
| Jun 30, 2023 | -74.46% |
| Mar 31, 2023 | -18.93% |
| Dec 31, 2022 | -30.55% |
| Sep 30, 2022 | 88.24% |
| Jun 30, 2022 | -70.81% |
| Mar 31, 2022 | -22.43% |
| Dec 31, 2021 | -26.47% |
| Sep 30, 2021 | 15.44% |
| Jun 30, 2021 | 17.65% |
| Mar 31, 2021 | 47.08% |
| Dec 31, 2020 | -2.63% |
| Sep 30, 2020 | 5.89% |
| Jun 30, 2020 | 29.79% |
| Mar 31, 2020 | 57.20% |
| Dec 31, 2019 | 21.08% |
| Sep 30, 2019 | 38.35% |
| Jun 30, 2019 | 37.25% |
| Mar 31, 2019 | 96.77% |
| Dec 31, 2018 | 294.35% |
| Sep 30, 2018 | 130.66% |
| Jun 30, 2018 | 107.96% |
| Mar 31, 2018 | 68.37% |
| Dec 31, 2017 | 78.28% |
| Sep 30, 2017 | 46.08% |
| Jun 30, 2017 | 36.67% |
| Mar 31, 2017 | 31.01% |
| Dec 31, 2016 | 36.05% |
| Sep 30, 2016 | 32.38% |
| Jun 30, 2016 | 33.90% |
| Mar 31, 2016 | 28.44% |
| Dec 31, 2015 | 28.81% |
| Sep 30, 2015 | 49.07% |
| Jun 30, 2015 | 40.52% |
| Mar 31, 2015 | -28.59% |
| Dec 31, 2014 | 24.50% |
| Sep 30, 2014 | 11.44% |
| Jun 30, 2014 | -36.40% |
| Mar 31, 2014 | -44.01% |
| Dec 31, 2013 | -37.28% |
| Sep 30, 2013 | -30.33% |
| Jun 30, 2013 | -20.53% |